Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GeNO Nitrosyl Delivery System in OHT/LVAD Candidates
NCT01165047Phase 2Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Sep 2010
- Primary completion
- Sep 2011
- Modality
- Transdermal Patches, Inhalation Devices, Hydrogel Systems
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Nitric oxide-releasing solution in pulmonary hypertension (PH), sponsored by Wake Forest University Health Sciences. Primary endpoint: Number of Participants With Side Effects and/or Adverse Events at 5 days. Started Sep 2010; status: completed.
02
Drugs
Nitric oxide-releasing solution
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT01165047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01165047.